Bionexus Gene Lab CEO Sook Keng Yeoh resigns effective Oct 4; no successor named yet

BioNexus Gene Lab Corp

CEO Sook Keng Yeoh resigned as CEO and director on October 4, 2023.
Resignation was not due to any disagreement with the Company, management, or Board.
Company currently has no CEO and is actively seeking a replacement.
President Yee Meng Wong remains; no interim CEO appointed at this time.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sook Keng Yeoh

Chief Executive Officer

BGLC · BioNexus Gene Lab Corp

Effective: 2023-10-04
Filed: October 11, 2023, 7:59 PM ET

On October 4, 2023, Mr. Sook Keng Yeoh, the Chief Executive Officer and a member of the Board of Directors, tendered his resignation letter to Bionexus Gene Lab Corp. (the “Company”) from his positions at the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sook Keng Yeoh resigned as Chief Executive Officer at BioNexus Gene Lab Corp.

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

On October 4, 2023, Mr. Sook Keng Yeoh, the Chief Executive Officer and a member of the Board of Directors, tendered his resignation letter to Bionexus Gene Lab Corp. (the “Company”) from his positions at the Company.

View on SEC.gov

BioNexus Gene Lab Corp filing history →

Source: SEC EDGAR

accession 0001477932-23-007555

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.